HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The significance of the pre-challenge immune status of mice for development of retrovirus-induced immunodeficiency syndrome (MAIDS).

Abstract
The effects of vaccination with RNA-free viral pseudoparticles, preinfection with non-pathogenic ecotropic virus, and induction of tolerance to viral proteins in newborns on the outcome of murine immunodeficiency syndrome (MAIDS) were studied. The parameters used to follow disease progression were: lymphopenia, circulating B and T8 cells, serum IgG and IgM levels, lymphoproliferation and skin graft rejection. Immunization with RNA-free viral pseudoparticles had no effect on any of these parameters. Preinfection of adults with ecotropic virus and the induction of tolerance in newborns to virus antigens both attenuated the early symptoms of viral infection and delayed the onset of immunodeficiency and lymphoproliferation in some mice, but did not significantly alter the number of deaths due to MAIDS. Failure of immune-based therapy to produce successful protection against MAIDS suggests that immune destruction caused by the persistent virus rather than hyperimmune activity is the main pathogenic factor in this disease.
AuthorsJ H Pavlovitch, M Rizk-Rabin, F Picard, M Marussig, A Halbreich
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 96 Issue 1 Pg. 64-8 (Apr 1994) ISSN: 0009-9104 [Print] England
PMID8149668 (Publication Type: Journal Article)
Chemical References
  • Viral Vaccines
Topics
  • Animals
  • CD4-CD8 Ratio
  • Female
  • Immune Tolerance
  • Leukemia Virus, Murine (immunology)
  • Leukocyte Count
  • Mice
  • Mice, Inbred C57BL
  • Murine Acquired Immunodeficiency Syndrome (blood, immunology)
  • T-Lymphocyte Subsets (immunology)
  • Viral Vaccines (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: